IQVIA CSMS GmbH provides services to the medical and pharmaceutical industry in Medical Science as well as marketing and sales of pharmaceuticals and other healthcare products and is authorized to perform temporary employment, placement, hiring, selection and training of temporary workers. The company is part of the IQVIA Group and the global Business Unit 'Contract Sales and Medical Solutions' and additionally offers patient support programs as well as, since 2021, decentralized patient visits in the context of clinical studies. In the 2024 financial year IQVIA CSMS generated revenue of EUR 47,350,516.43, employed on average 438 staff and reported a net profit of EUR 1,190,803.08.
Die Erbringung von Dienstleistungen für die medizinische und pharmazeutische Industrie in den Bereichen Medizinische Wissenschaft, Marketing und Vertrieb von Arzneimitteln und anderen Produkten des Gesundheitsbereichs sowie alle damit zusammenhängenden Tätigkeiten. Die Gesellschaft ist weiterhin berechtigt, folgende Geschäftstätigkeiten auszuüben: Arbeitnehmerüberlassung; Angebots- und nachfrageorientierte Vermittlungstätigkeit am Arbeitsmarkt; Einstellung, Auswahl und Fortbildung von Leiharbeitnehmern.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 6679 (as of 1 November 2026)
| Name | Type | City |
|---|---|---|
| Richard Laven | Geschäftsführer(in) | Hirschberg an der Bergstraße |
| Frank Wartenberg | Geschäftsführer(in) | Königstein im Taunus |
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 6679 (as of 1 November 2026)
| Date | Event Type | Event |
|---|---|---|
| 15.10.2025 | Registered Seat Change | IQVIA CSMS GmbH, 20124 Milano/Italien |
| 15.10.2025 | Business Address Change | Via Fabio Filzi 29, 20124 Milano/Italien |
| 23.09.2024 | Business Address Change | P7, 20-21, 68161 Mannheim |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 19.03.2020 | Capital Increase | +1.460.000 € | 6.660.000 € |
| 24.10.2005 | Share Capital Set | — | 5.200.000 DM |
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 6679 (as of 1 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2025 | €49,860,147 | €2,580,135 | €30,677,230 | — |
| 2024 | €47,350,516 | €1,366,796 | €25,444,385 | — |
| 2023 | €37,856,200 | €96,385 | €24,127,366 | — |
| 2022 | €33,178,896 | -€1,586,373 | €21,756,656 | — |
| 2021 | €36,939,744 | €2,199,244 | €28,116,859 | — |
| 2020 | €44,707,741 | €2,511,593 | €21,983,776 | — |
| 2019 | €43,999,075 | -€2,699,659 | €19,910,678 | — |
| 2018 | €60,642,401 | -€3,390,353 | €16,562,936 | — |
| 2017 | €71,444,491 | -€186,226 | €21,965,466 | — |
| 2016 | €72,467,587 | €1,720,926 | €20,426,362 | — |
Sign in to download data
Source: German Commercial Register (Handelsregister) Mannheim Local Court, HRB 6679 (as of 1 November 2026)
Gesellschaft für Systemberatung im Gesundheitswesen GSbG mbH
Grünwald · Vermittlungstätigkeiten für medizinische, zahnärztliche und andere Gesundheitstätigkeiten
FL Innovation GmbH
Raubling · Vermittlungstätigkeiten für medizinische, zahnärztliche und andere Gesundheitstätigkeiten
DERMANOVIS Holding GmbH
München · Beteiligungsgesellschaften
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €34,649,143 | 98.8% |
| Depreciation | €270,728 | 0.8% |
| Interest & Similar | €149,414 | 0.4% |
